compound introduction
GSK8573 is an inactive control compound for GSK2801 (acetyl-lysine competitive inhibitor of BAZ2A and BAZ2B bromodomains). GSK8573 has binding activity to BRD9 with a K d value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain familiy. GSK8573 can be used as a structurally related negative control compound in biological experiments In Vitro GSK8573 (1.0 μM) has binding activity to BRD9 with a K d value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain family. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:BRD9 1.04 μM (Kd)
